Rising Tide: Postural Orthostatic Tachycardia Syndrome (POTS)

As a family physician, I've witnessed a troubling surge in cases of postural orthostatic tachycardia syndrome (POTS), a form of dysautonomia that disrupts the autonomic nervous system's ability to regulate heart rate and blood pressure upon standing.

Over the past few years, particularly since the onset of the COVID-19 pandemic, I've seen this condition disproportionately affect young teenage girls — vibrant, active individuals suddenly sidelined by dizziness, fatigue, palpitations, and brain fog that make school, sports, and social life a daily battle. What strikes me most is the temporal link: many of these cases emerge shortly after a bout of COVID-19 infection or, less commonly, following vaccination.

This isn't anecdotal; it's a pattern echoed in clinics worldwide. POTS, characterized by an excessive heart rate increase (by ≥40 beats per minute in adolescents) within 10 minutes of standing without significant blood pressure drop, has long been a puzzle. But the pandemic seems to have dramatically increased the number of cases, revealing potential triggers rooted in viral proteins and immune dysregulation.

The Spike Protein: A Double-Edged Sword

At the heart of this rise lies the SARS-CoV-2 spike protein — the virus's key to invading cells via the ACE2 receptor. Infection floods the body with this protein, provoking inflammation and immune chaos that can linger as "long COVID." Studies show POTS emerging in up to 2–14% of post-COVID patients, often in those under 50, with symptoms peaking months later.

In adolescents, this manifests as orthostatic intolerance, where standing triggers a cascade of sympathetic overdrive: heart racing to compensate for blood pooling in the legs, leading to lightheadedness and collapse. COVID vaccination may cause this same phenomenon by instructing cells to produce a modified spike protein, triggering the immune system to over-react in some cases, causing a hyperimmune response that may result in autonomic neurological dysfunction. Although post-vaccine POTS is less common than post-infection, a 2024 systematic review in BMC Cardiovascular Disorders analyzed 20 studies, finding temporal associations in adolescents after mRNA doses.

Proposed mechanisms:

• Molecular mimicry: vaccine-induced antibodies cross-react with autonomic receptors (e.g., adrenergic or ganglionic acetylcholine), mimicking viral damage
• Exaggerated immune responses via lipid nanoparticles, amplifying transient autonomic glitches
• Infection poses a 5-fold higher POTS odds than vaccination, per a 2023 Nature Cardiovascular Research analysis of millions

Beyond COVID: A Viral Family Affair

POTS isn't new to viruses. Pre-pandemic, 28–41% of cases traced to infections like Epstein-Barr (mono), influenza, enteroviruses, or Lyme disease — all capable of triggering autoimmunity or nerve inflammation.

Other contributing factors include Ehlers-Danlos syndrome (connective tissue laxity aiding blood pooling), deconditioning from illness, or even surgery and pregnancy. In teens, hormonal flux during puberty amplifies vulnerability, explaining the girl-heavy skew (5:1 female-to-male ratio).

Diagnosis

Testing approach:

• Active stand test or tilt table for HR spikes — the cornerstone diagnostic
• EKG/Holter for arrhythmias; echocardiogram for structural heart issues (normal in pure POTS)
• EEG if seizures are suspected; brain MRI excludes strokes or tumors
• Spike antibody testing to gauge exposure; elevated G-protein-coupled receptor autoantibodies flag autoimmunity in 20–30% of POTS cases
• ANA, aPL for broader autoimmunity — positive in 25–31% vs. 16% general population

Treatment

Non-pharmacologic (cornerstone):

• Hydration (2–3L/day) and salt (3–10g/day) combat hypovolemia — electrolyte drinks, not just water
• Compression stockings and counter-maneuvers (leg crossing)
• Graded exercise: start recumbent biking, progress to upright activity

Pharmacologic options:

• Beta-blockers (low-dose propranolol) tame tachycardia in hyperadrenergic POTS — improving symptoms 70–80% short-term
• Fludrocortisone boosts volume via salt retention — gold for hypovolemics, but monitor potassium
• Ivabradine for pure sinus tachycardia — HR reduction without beta effects
• SSRIs/SNRIs for comorbid fog/anxiety (not first-line)

Referrals:

• Neurologists for autonomic dysregulation
• Cardiologists for cardiac rehabilitation
• Multidisciplinary clinics yield the best outcomes

Summary

The surge in POTS, especially among teenage girls since the pandemic, is a clinical reality which cannot be ignored. Whether triggered by the inflammatory storm of SARS-CoV-2 infection or, less commonly, by an aberrant immune response to vaccination, the spike protein appears capable of disrupting autonomic regulation in susceptible individuals.

Early recognition, thorough cardiac and autonomic testing, aggressive non-pharmacologic therapy, and judicious use of medications can restore function for the majority of patients — often dramatically. The path forward is clear: listen to the patient's symptoms, validate their struggle, investigate rigorously, and treat compassionately.

With timely intervention, most will not just cope with POTS — they will outgrow it and reclaim the active, vibrant lives that were momentarily stolen from them.

---

Dr. Kurt Bravata M.D. is the author of Live Free or Diet and the founder of Holistic Human. This content is for educational purposes only and does not constitute medical advice.